🇺🇸 FDA
Patent

US 8865719

Substituted heterocycles and their use as allosteric modulators of nicotinic and GABAA receptors

granted A61PA61P1/04A61P21/02

Quick answer

US patent 8865719 (Substituted heterocycles and their use as allosteric modulators of nicotinic and GABAA receptors) held by The Regents of the University of California expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/04, A61P21/02, A61P25/00, A61P25/04